Grant: Collaborative Health Research Projects
University of Toronto
$97,872.00
Temperature measurement in cortical bone and bone marrow during magnetic resonance guided focused ultrasound thermotherapy in a porcine model
EF 2014-15
Résumé
Current localized treatments of benign bone tumours in children suffer from significant side effects including the invasivenessof surgical removal with bone reconstruction, and the associated risk of developing secondary malignancy from high-doseradiation therapy. Magnetic resonance guided focused ultrasound (MRgFUS) is a noninvasive thermo-therapy that hasrecently been clinically approved in Canada for uterine fibroid ablation and is currently in clinical trials in Canada for palliativemanagement of bone metastasis pain. It is also showing promise as an effective local treatment, when combined withchemotherapy, for malignancies throughout the body. The principle therapeutic technique underlying MRgFUS is thenoninvasive focusing of high intensity ultrasound energy to induce thermal necrosis in a target volume as small as a ricekernel. Localized temperature elevations in the target tissue can be monitored noninvasively and in real time inside a clinicalmagnetic resonance imaging (MRI) scanner. However, conventional MRI thermometry is limited to water-based soft tissues,such as muscle, and temperature is not measured in cortical bone and fat-based tissues such as bone marrow, preventingits use as a primary local treatment for bone tumours. Since many bone tumours grow within both the cortical bone and bonemarrow, accurate assessment of temperature in both of these tissues during treatment is required to ensure adequatethermal necrosis. We hypothesize that bone marrow temperature can be measured accurately by quantifying the change inmagnetic relaxation time of the fat-rich bone marrow during heating, and that the temperature distribution across the corticalbone can be calculated from the surrounding measured temperatures in the muscle and bone marrow. This method willenable the safe application of MRgFUS for local treatments of benign bone neoplasms and will improve treatment andquality of life for paediatric bone tumour patients.
Programme
Collaborative Health Research Projects
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
446430-2013
Name nom
Drake, James
Department département
Medicine, Faculty of
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2013
Award amount
97872
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Partie
2 & 3
Nb partie
3
Application title
Temperature measurement in cortical bone and bone marrow during magnetic resonance guided focused ultrasound thermotherapy in a porcine model
Keyword
NSERC
Application summary
Current localized treatments of benign bone tumours in children suffer from significant side effects including the invasivenessof surgical removal with bone reconstruction, and the associated risk of developing secondary malignancy from high-doseradiation therapy. Magnetic resonance guided focused ultrasound (MRgFUS) is a noninvasive thermo-therapy that hasrecently been clinically approved in Canada for uterine fibroid ablation and is currently in clinical trials in Canada for palliativemanagement of bone metastasis pain. It is also showing promise as an effective local treatment, when combined withchemotherapy, for malignancies throughout the body. The principle therapeutic technique underlying MRgFUS is thenoninvasive focusing of high intensity ultrasound energy to induce thermal necrosis in a target volume as small as a ricekernel. Localized temperature elevations in the target tissue can be monitored noninvasively and in real time inside a clinicalmagnetic resonance imaging (MRI) scanner. However, conventional MRI thermometry is limited to water-based soft tissues,such as muscle, and temperature is not measured in cortical bone and fat-based tissues such as bone marrow, preventingits use as a primary local treatment for bone tumours. Since many bone tumours grow within both the cortical bone and bonemarrow, accurate assessment of temperature in both of these tissues during treatment is required to ensure adequatethermal necrosis. We hypothesize that bone marrow temperature can be measured accurately by quantifying the change inmagnetic relaxation time of the fat-rich bone marrow during heating, and that the temperature distribution across the corticalbone can be calculated from the surrounding measured temperatures in the muscle and bone marrow. This method willenable the safe application of MRgFUS for local treatments of benign bone neoplasms and will improve treatment andquality of life for paediatric bone tumour patients.